Who needs an invoice right now? Nobody. That’s why we have deferred all upcoming renewals/fees until 1st July and will review this regularly.
However, that won’t stop us talking to you and exercising your brains with webinars and fun stuff over the coming weeks.
#StayAtHome
Congratulations to Katherine Klein of the Hilton, Munich Airport who was the winner of our fun Compliance Caveman challenge furing M&I Healthcare, Helisnki.
Over 70 people took part … some multiple times … demonstrating the competitive nature of our industry and how passionate people are to demonstrate their Compliance for Healthcare Meetings and Events skills !
Our very own Simon Beard kicked off, to a packed room, how the supplier group should use their new found specialism for Healthcare sector meetings and events to positively impact on the quality and outcomes from their 15 minute, 1:1 appointments.
The state of New Jersey in the US has been active since 2017 in creating a gift ban essentially, the controlling of the amount a healthcare company can pay a Healthcare professionals (HCP) for services and for financial limits to meals. On May 6, the New Jersey Attorney General, Gurbir S. Grewal, finalized and made effective amendments to the rules governing physician interactions with pharmaceutical companies which we have summarised below.
Please note these are our interpretations of the rules and should be used accordingly. To learn more contacts [email protected]
The Attorney General clarified that the rules do not apply to manufacturers of medical devices and “clarif[ied] that the rules . . . do not apply to prescribers..interactions with pharmaceutical manufacturers to the extent that such pharmaceutical manufacturers also manufacture medical devices and that such interactions are directed solely to medical devices.” This means that rules apply only to prescribers; interactions with pharmaceutical manufacturers concerning prescription drugs or biologics.
No changes were made to the proposed meal limitations that apply to promotional activities ($15.00 for breakfast and lunch; $30.00 for dinners). The meal limits do not apply to an “education event” nor the $10,000 bona fide services cap.
In each succeeding calendar year after 2018, the meal limits amounts are adjusted if the Consumer Price Index reflects a sum, which, if rounded, consistent with the regulation’s definition of Consumer Price Index,” would raise it by one-dollar increments. The fair market value shall not include the cost of standard delivery, service, or facility rental fee charges, or of tax.
Payments for research activities and payments to prescribers for speaking at education events are not subject to the bona fide services cap.
The definition now includes (1) information about disease states and treatment options and (2) specify that notwithstanding the FDA’s classification of a program as promotional, programs that meet New Jersey’s definition of education event are deemed education events.
Healthcare-Venues: Our interpretation of an educational event it is any meeting or event that is non-promotional.
The rules should apply equally to all prescribers licensed by the State and that no distinction should be made for where the prescribers regularly practice.” The definition, as adopted, “means a physician, podiatrist, physician assistant, advanced practice nurse, dentist, or optometrist who has an active license [and] does not include a licensee who is an employee . . . of a pharmaceutical manufacturer who does not provide patient care.”
Healthcare-Venues: It will be interesting to see how companies interpret this to out of state meetings.
Research means any study assessing the safety or efficacy of prescribed products administered alone or in combination with other prescribed products or other therapies, or assessing the relative safety or efficacy of prescribed products in comparison with other prescribed products or other therapies, or any *[systemic]* *systematic* investigation, including scientific advising on the development, testing, and evaluation, that is designed to develop or contribute to general knowledge, or reasonably can be considered to be of significant interest or value to scientists or prescribers working in a particular field. Research shall include both pre-market and post-market activities that satisfy the requirements of this definition.
Healthcare-Venues: Our interpretation is that investigator and associated research-based meetings are exempt
At 3Sixty, Betsy was more than an expert in meetings strategy—she was a beacon of kindness, professionalism, and fierce pride in the work she did. Her expertise in the healthcare sector and deep understanding of the US meetings matrix helped shape our success on an international scale. Betsy had over 30 years of experience in meeting and trade show management, hotel sales, and procurement, but her passion for advancing the industry went beyond any résumé. She was a pioneer, developing one of the earliest Strategic Meetings Management (SMM) programs for the world’s largest biotech company and creating venue compliance processes for the PhRMA guidelines.
Betsy was never content to simply follow; she led by example. She set up her own consultancy in 2007, sharing her wealth of knowledge through countless articles, presentations, and educational programs. Her influence reached across America, Europe, and Asia, where she championed the importance of meetings and, most importantly, the people behind them. Her unwavering enthusiasm and commitment touched everyone who had the privilege of working with her. Betsy brought not just expertise, but also warmth and generosity, creating lasting bonds with colleagues and clients alike.
This page will remain as a tribute to Betsy’s incredible character and her tireless work to advance the meetings industry. She may no longer be with us in person, but her spirit, her passion, and her extraordinary contributions will continue to inspire us all. Rest in peace, Betsy.
Mark’s career has seen him master a number of operational roles to become Director of global event management company World Events (now Ashfield Meetings), then Head of Global Events for F. Hoffmann La Roche where he established global compliance guidelines and the integration of 35 markets into a centralised solution.
More recently he worked with Grass Roots to create an aligned international multi-market offer for meetings and events, before becoming Director of 3Sixty Event Consulting and founding our independent venue compliance index healthcare-venues.com. When he’s not deeply involved in developing our own strategic and collaborative offering he is also an expert advisor to Plenum, a peer-to-peer networking group, through which he passionately contributes to the global dialogue around Healthcare meetings and events.
His consultancy experience has given him unrivalled industry insight into strategic meetings management, future trends and HCP engagement.
Simon is a specialist in Healthcare Sector meetings, with a finely tuned understanding of successful events across the product lifecycle. He has supported numerous top-level Healthcare and Life Science companies in developing clinical programmes, coordinating launch activities, and delivering engagement-driven meetings for internal and external audiences.
Recent Comments